MA46786A - Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcoolique - Google Patents
Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcooliqueInfo
- Publication number
- MA46786A MA46786A MA046786A MA46786A MA46786A MA 46786 A MA46786 A MA 46786A MA 046786 A MA046786 A MA 046786A MA 46786 A MA46786 A MA 46786A MA 46786 A MA46786 A MA 46786A
- Authority
- MA
- Morocco
- Prior art keywords
- patients
- hepatic steatosis
- alcoholic hepatic
- fibrosis inhibition
- fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662420009P | 2016-11-10 | 2016-11-10 | |
| US201762475132P | 2017-03-22 | 2017-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46786A true MA46786A (fr) | 2019-09-18 |
Family
ID=61024797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046786A MA46786A (fr) | 2016-11-10 | 2017-11-10 | Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcoolique |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20190275061A1 (fr) |
| EP (1) | EP3538159B1 (fr) |
| JP (1) | JP2019537607A (fr) |
| KR (1) | KR20190083660A (fr) |
| CN (1) | CN110062634A (fr) |
| AU (1) | AU2017357868A1 (fr) |
| BR (1) | BR112019009509A2 (fr) |
| CA (1) | CA3043286A1 (fr) |
| IL (1) | IL266528A (fr) |
| MA (1) | MA46786A (fr) |
| MX (1) | MX2019005531A (fr) |
| WO (1) | WO2018087600A1 (fr) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123998A (en) * | 1998-04-08 | 2004-09-27 | Galmed Int Ltd | Conjugates of bile salts and pharmaceutical preparations containing them |
| US9750718B2 (en) * | 2012-12-12 | 2017-09-05 | The Charlotte-Mecklenburg Hospital Authority | Methods of treating hepatic fibrosis and associated diseases by regulating Rev-ERB activity |
| PT3077047T (pt) * | 2013-12-04 | 2019-07-11 | Galmed Res & Development Ltd | Sais de aramchol |
| CN107106873A (zh) * | 2015-01-09 | 2017-08-29 | 吉利德阿波罗公司 | 用于治疗非酒精性脂肪肝病的acc抑制剂组合治疗 |
| WO2017017677A1 (fr) * | 2015-07-27 | 2017-02-02 | Galmed Research And Development Ltd. | Polythérapie pour maladies du foie |
-
2017
- 2017-11-10 WO PCT/IB2017/001535 patent/WO2018087600A1/fr unknown
- 2017-11-10 JP JP2019524916A patent/JP2019537607A/ja active Pending
- 2017-11-10 AU AU2017357868A patent/AU2017357868A1/en not_active Abandoned
- 2017-11-10 MA MA046786A patent/MA46786A/fr unknown
- 2017-11-10 CN CN201780076419.7A patent/CN110062634A/zh active Pending
- 2017-11-10 KR KR1020197016405A patent/KR20190083660A/ko not_active Application Discontinuation
- 2017-11-10 CA CA3043286A patent/CA3043286A1/fr not_active Abandoned
- 2017-11-10 BR BR112019009509A patent/BR112019009509A2/pt not_active Application Discontinuation
- 2017-11-10 US US16/348,158 patent/US20190275061A1/en not_active Abandoned
- 2017-11-10 EP EP17835491.6A patent/EP3538159B1/fr active Active
- 2017-11-10 MX MX2019005531A patent/MX2019005531A/es unknown
-
2019
- 2019-05-08 IL IL266528A patent/IL266528A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110062634A (zh) | 2019-07-26 |
| MX2019005531A (es) | 2019-09-16 |
| AU2017357868A1 (en) | 2019-06-27 |
| CA3043286A1 (fr) | 2018-05-17 |
| KR20190083660A (ko) | 2019-07-12 |
| EP3538159B1 (fr) | 2023-04-05 |
| EP3538159A1 (fr) | 2019-09-18 |
| BR112019009509A2 (pt) | 2019-07-30 |
| WO2018087600A1 (fr) | 2018-05-17 |
| JP2019537607A (ja) | 2019-12-26 |
| US20190275061A1 (en) | 2019-09-12 |
| IL266528A (en) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266780A (en) | Modified RNA materials with reduced off-target effect | |
| MA43515A (fr) | Méthodes et compositions d'inhibition de l'interaction de la ménine avec les protéines mll | |
| MA47555A (fr) | Formation dans la distribution d'un médicament | |
| FR3016768B1 (fr) | Utilisation d'une composition enzymatique dans l'alimentation des ruminants | |
| ZA201704957B (en) | Composition for the treatment of hepatic veno-occlusive disease | |
| FR3002454B1 (fr) | Composition immunogene sous forme d'emulsion | |
| HK1243709A1 (zh) | 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物 | |
| MA43764A (fr) | Inhibiteur monovalent de l'interaction hutnfr1 | |
| MA46786A (fr) | Inhibition de la fibrose chez des patients atteints d'une stéatose hépatique non alcoolique | |
| FR3024836B1 (fr) | Emulsion sous forme huile-dans-eau | |
| Billowes et al. | Lönsamhet med att planera i 4D: En utredning när lönsamhet uppstår vid planering i 4D | |
| GB201617280D0 (en) | Improvements in or relating to tilling | |
| GB201610543D0 (en) | Driving range tee's | |
| UA33839S (uk) | Етикетка для води питної «хіт продукт» | |
| AU364102S (en) | Alu' Lounger | |
| AU364006S (en) | Alu' lounger | |
| GB201617495D0 (en) | Improvements in or relating to continuous printers | |
| GB201500288D0 (en) | John's closet | |
| AU364081S (en) | Alu' sofa | |
| AU364080S (en) | Alu' sofa | |
| AU364079S (en) | Alu' sofa | |
| AU364068S (en) | Alu' Sofa | |
| AU364121S (en) | Alu' sofa | |
| AU363985S (en) | Alu' plastic chair | |
| GB201518012D0 (en) | Improvements in or relating to tilling |